Inger Schousboe

2.2k total citations
54 papers, 1.8k citations indexed

About

Inger Schousboe is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Inger Schousboe has authored 54 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Genetics and 18 papers in Hematology. Recurrent topics in Inger Schousboe's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Vitamin K Research Studies (9 papers). Inger Schousboe is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Vitamin K Research Studies (9 papers). Inger Schousboe collaborates with scholars based in Denmark, United States and Hungary. Inger Schousboe's co-authors include Arne Schousboe, Rasmus Røjkjær, Georgi Gegelashvili, Gianluca Civenni, Niels C. Danbolt, Giorgio Racagni, Tanja Kveder, Marielle Sanmarco, J Arvieux and Anǵela Tincani and has published in prestigious journals such as Journal of Clinical Investigation, Blood and FEBS Letters.

In The Last Decade

Inger Schousboe

54 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inger Schousboe Denmark 24 664 620 470 322 318 54 1.8k
Wentian Yang United States 30 194 0.3× 234 0.4× 2.2k 4.7× 103 0.3× 95 0.3× 51 3.5k
C. M. Petersen Denmark 17 95 0.1× 325 0.5× 667 1.4× 133 0.4× 39 0.1× 22 1.6k
Rina Aharoni Israel 34 289 0.4× 87 0.1× 573 1.2× 341 1.1× 277 0.9× 71 3.3k
Yoshihisa Oguchi Japan 34 89 0.1× 188 0.3× 1.8k 3.9× 230 0.7× 1.6k 4.9× 126 4.3k
J. Kawagoe Japan 20 70 0.1× 498 0.8× 710 1.5× 289 0.9× 29 0.1× 37 1.6k
Hans‐Peter Hartung Germany 28 117 0.2× 124 0.2× 456 1.0× 1.3k 4.1× 486 1.5× 57 2.8k
May Christine V. Malicdan United States 29 188 0.3× 117 0.2× 1.5k 3.1× 185 0.6× 30 0.1× 126 2.6k
Eiichi Tani Japan 31 167 0.3× 72 0.1× 1.4k 2.9× 498 1.5× 62 0.2× 123 3.2k
Carolina R. Jost Netherlands 24 92 0.1× 106 0.2× 926 2.0× 175 0.5× 493 1.6× 44 1.8k
Margaret M. Halloran United States 13 273 0.4× 106 0.2× 483 1.0× 48 0.1× 126 0.4× 17 1.3k

Countries citing papers authored by Inger Schousboe

Since Specialization
Citations

This map shows the geographic impact of Inger Schousboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Schousboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Schousboe more than expected).

Fields of papers citing papers by Inger Schousboe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Schousboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Schousboe. The network helps show where Inger Schousboe may publish in the future.

Co-authorship network of co-authors of Inger Schousboe

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Schousboe. A scholar is included among the top collaborators of Inger Schousboe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Schousboe. Inger Schousboe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schousboe, Arne, et al.. (2011). Neuron–glia interactions in glutamatergic neurotransmission: Roles of oxidative and glycolytic adenosine triphosphate as energy source. Journal of Neuroscience Research. 89(12). 1926–1934. 41 indexed citations
2.
Schousboe, Inger, et al.. (2009). High molecular weight kininogen binds to laminin – characterization and kinetic analysis. FEBS Journal. 276(18). 5228–5238. 6 indexed citations
3.
Schousboe, Inger. (2007). Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation. Biochemical Pharmacology. 75(5). 1007–1013. 21 indexed citations
4.
Schousboe, Inger. (2006). Endothelial cells express a matrix protein which binds activated factor XII in a zinc-independent manner. Thrombosis and Haemostasis. 95(2). 312–319. 9 indexed citations
5.
Schousboe, Inger, et al.. (2006). Effect of topiramate and dBcAMP on expression of the glutamate transporters GLAST and GLT-1 in astrocytes cultured separately, or together with neurons. Neurochemistry International. 48(6-7). 657–661. 10 indexed citations
6.
Schousboe, Inger, Peter Thomsen, & Bo van Deurs. (2004). Factor XII binding to endothelial cells depends on caveolae. European Journal of Biochemistry. 271(14). 2998–3005. 7 indexed citations
7.
Reber, Guido, Inger Schousboe, Anǵela Tincani, et al.. (2002). Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.. PubMed. 88(1). 66–73. 99 indexed citations
8.
Schousboe, Inger. (2002). Binding of activated Factor XII to endothelial cells affects its inactivation by the C1‐esterase inhibitor. European Journal of Biochemistry. 270(1). 111–118. 25 indexed citations
9.
Moestrup, Søren K., et al.. (1998). beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.. Journal of Clinical Investigation. 102(5). 902–909. 74 indexed citations
10.
Schousboe, Inger. (1997). Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+. Blood Coagulation & Fibrinolysis. 8(2). 97–104. 14 indexed citations
11.
Røjkjær, Rasmus & Inger Schousboe. (1997). The Surface‐Dependent Autoactivation Mechanism of Factor XII. European Journal of Biochemistry. 243(1-2). 160–166. 36 indexed citations
13.
Schousboe, Inger & Torben Halkier. (1991). Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high‐Mr kininogen. European Journal of Biochemistry. 197(2). 309–314. 10 indexed citations
14.
Kristensen, Torsten Nygaard, et al.. (1991). Molecular cloning and mammalian expression of human β2‐glycoprotein I cDNA. FEBS Letters. 289(2). 183–186. 45 indexed citations
16.
Schousboe, Inger, Orla M. Larsson, & Arne Schousboe. (1989). Development of homospecific activity of GABA‐transaminase in the mouse cerebral cortex and cerebellum and in neurons cultured from these brain areas. International Journal of Developmental Neuroscience. 7(1). 115–121. 10 indexed citations
17.
Schousboe, Inger, et al.. (1988). The effect of β2-glycoprotein i on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation. International Journal of Biochemistry. 20(8). 787–792. 22 indexed citations
18.
Schousboe, Inger. (1988). Inositolphospholipid‐accelerated activation of prekallikrein by activated factor XII and its inhibition by β2‐glycoprotein I. European Journal of Biochemistry. 176(3). 629–636. 27 indexed citations
19.
20.
Schousboe, Inger. (1976). Triacylglycerol lipase activity in baker's yeast (Saccharomyces cerevisiae). Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 424(3). 366–375. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026